- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/10 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles
Patent holdings for IPC class C07D 271/10
Total number of patents in this class: 445
10-year publication summary
|
46
|
42
|
32
|
36
|
28
|
24
|
22
|
23
|
17
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chong Kun Dang Pharmaceutical Corp. | 245 |
25 |
| Denali Therapeutics Inc. | 261 |
10 |
| Modernatx, Inc. | 1280 |
10 |
| Merck Sharp & Dohme LLC | 3723 |
10 |
| Abbvie Inc. | 1842 |
9 |
| Reata Pharmaceuticals, Inc. | 117 |
9 |
| Calico Life Sciences LLC | 104 |
9 |
| Takeda Pharmaceutical Company Limited | 2721 |
7 |
| Shionogi & Co., Ltd. | 863 |
7 |
| AstraZeneca AB | 2837 |
6 |
| SK Biopharmaceuticals Co., Ltd. | 273 |
6 |
| Novartis AG | 10345 |
5 |
| Merck Patent GmbH | 5663 |
5 |
| Bayer Cropscience AG | 1887 |
5 |
| Boehringer Ingelheim International GmbH | 4510 |
4 |
| Janssen Pharmaceutica N.V. | 3234 |
4 |
| Allergan, Inc. | 2208 |
4 |
| Canopy Growth Corporation | 211 |
4 |
| Cedars-Sinai Medical Center | 1189 |
4 |
| EA Pharma Co., Ltd. | 93 |
4 |
| Other owners | 298 |